MJBizDaily reported
that Health Canada’s order asking companies to stop selling certain
ingestible cannabis products could cost the industry millions of
dollars. According to the federal agency, these products were labeled as Extracts rather than Edibles.
- The
acting director general of the Compliance Directorate in Health Canada,
Anika Stella Chasse, wrote a letter to companies requesting they stop
selling such products.
- THC quantity in products labeled Extracts is 100 times more than in products labeled Edibles.
- Sources told MJBizDaily that lozenges and chewable extracts, the two products in question, are popular among their customers.
- According
to Shane Morris, founder of Morris & Associates Consulting, retail
outlets sell CA$ 33.9M (~$25.4M) of ingestible products per year in the
recreational market.
- Health Canada regulations require
companies to follow the Notice of New Cannabis Products (NNCP) process
and inform the agency months in advance about new products.
|
